1. A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis
- Author
-
Ángela Pecondón-Español, Jose A. Pinto-Tasende, José Ivorra-Cortés, Eugenio de Miguel, Manuel Castaño-Sánchez, Manuel Rodríguez-Gómez, Ricardo Gutierrez-Polo, Alfonso Corrales, and Jose L. Rivas
- Subjects
Adult ,Male ,medicine.medical_specialty ,Hand Joints ,Immunology ,Anti-Inflammatory Agents ,Lower risk ,Arthritis, Rheumatoid ,03 medical and health sciences ,0302 clinical medicine ,Rheumatology ,Remission criteria ,Foot Joints ,Internal medicine ,medicine ,Humans ,Immunology and Allergy ,Prospective Studies ,030212 general & internal medicine ,Aged ,Ultrasonography ,030203 arthritis & rheumatology ,Tumor Necrosis Factor-alpha ,business.industry ,Remission Induction ,Ultrasound ,Middle Aged ,medicine.disease ,Surgery ,Radiography ,Rheumatoid arthritis ,Radiological weapon ,Cohort ,Disease Progression ,Female ,Observational study ,business - Abstract
To study the predictive value of clinical remission definitions and ultrasound (US) examination on X-ray progression in rheumatoid arthritis (RA). This was an observational prospective multicenter 1-year follow-up cohort of RA patients with moderate disease activity (3.2 DAS28 ≤ 5.1) who started anti-TNF therapy. DAS28ESR, DAS28CRP, SDAI, CDAI, and ACR/EULAR remission criteria were applied and reduced 12-joint US examination was performed at baseline and at 6 and 12 months. At baseline and month 12, radiographs of hands and feet were obtained in a subset of patients. A blind independent reader scored radiographs. X-ray progression was defined as Sharp van der Heijde change score 1 and no progression was defined as ≤0. 319 of 357 patients completed the study; patients had a mean (SD) age of 53.5 (13.1) years, with a disease duration of 7.5 (7.1) years. Laboratory, clinical, and US values significantly improved at month 6, except CRP, with additional improvement at month 12. Remission and low disease activity rates increased at follow-up. In the subset of 115 patients with radiological studies, clinical remission by any definition was not significantly associated with X-ray progression. Patients without PD signal at baseline and month 6 were a lower risk of X-ray progression than patients with PD signal, OR 0.197 (95% CI 0.046-0.861) and 0.134 (95% CI 0.047-0.378), respectively. Absence of PD signal, but not clinical remission predicts lack of X-ray progression. A feasible 12-joint US examination may add relevant information to RA remission criteria.
- Published
- 2017